{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:59:37Z","timestamp":1768507177392,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128077","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T21:35:00Z","timestamp":1765488900000},"page":"128077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cost-effectiveness analyses of catch-up vaccination against human papillomavirus (HPV) related cancers of boys and young men in Sweden"],"prefix":"10.1016","volume":"72","author":[{"given":"Ellen","family":"Wolff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Schollin Ask","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2025.128077_bb0005","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1055-9965.EPI-12-1406","article-title":"Human papillomavirus infection and the multistage carcinogenesis of cervical cancer","volume":"22","author":"Schiffman","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2025.128077_bb0010","series-title":"P.s.V.-. Electronic","article-title":"Chapter 32 - human papillomavirus vaccines","volume":"vol. 8","author":"Orenstein","year":"2023"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128077_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/v15071440","article-title":"Recent developments in human papillomavirus (HPV) vaccinology","volume":"15","author":"Williamson","year":"2023","journal-title":"Viruses-Basel"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128077_bb0020","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"05","key":"10.1016\/j.vaccine.2025.128077_bb0025","doi-asserted-by":"crossref","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","article-title":"Updating the natural history of human papillomavirus and anogenital cancers","volume":"30 Suppl 5","author":"Moscicki","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128077_bb0030","doi-asserted-by":"crossref","first-page":"e692","DOI":"10.1093\/cid\/ciac581","article-title":"Incidence and clearance of anal human papillomavirus infection in 16 164 individuals, according to human immunodeficiency virus status, sex, and male sexuality: an international pooled analysis of 34 longitudinal studies","volume":"76","author":"Wei","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128077_bb0035","author":"Socialstyrelsen"},{"key":"10.1016\/j.vaccine.2025.128077_bb0040","author":"Folkh\u00e4lsomyndigheten"},{"key":"10.1016\/j.vaccine.2025.128077_bb0045","author":"Folkh\u00e4lsomyndigheten"},{"issue":"34","key":"10.1016\/j.vaccine.2025.128077_bb0050","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1016\/j.vaccine.2018.07.018","article-title":"Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour","volume":"36","author":"Wolff","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128077_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2239085","article-title":"Human papillomavirus vaccine effectiveness by age at vaccination: a systematic review","volume":"19","author":"Ellingson","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128077_bb0060","series-title":"Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2020"},{"key":"10.1016\/j.vaccine.2025.128077_bb0065","author":"FASS"},{"key":"10.1016\/j.vaccine.2025.128077_bb0070","author":"FASS"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128077_bb0075","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-world effectiveness of human papillomavirus vaccination against cervical Cancer","volume":"113","author":"Kjaer","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128077_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050669","article-title":"Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial","volume":"11","author":"Lehtinen","year":"2021","journal-title":"BMJ Open"},{"issue":"14","key":"10.1016\/j.vaccine.2025.128077_bb0085","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical Cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128077_bb0090","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jnci\/djad263","article-title":"Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation","volume":"116","author":"Palmer","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2025.128077_bb0095","article-title":"Effectiveness of quadrivalent human papillomavirus vaccination against high-grade cervical lesions by age and doses: a population-based cohort study","volume":"49","author":"Wu","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.vaccine.2025.128077_bb0100","author":"Statistiska centralbyr\u00e5n (SCB)"},{"issue":"46","key":"10.1016\/j.vaccine.2025.128077_bb0105","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/j.vaccine.2011.07.096","article-title":"The cost-effectiveness of male HPV vaccination in the United States","volume":"29","author":"Chesson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128077_bb0110","series-title":"Statistics, Data Query, HPV prevalence estimates - HPV type distribution","author":"HPV Information Centre","year":"2025"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128077_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2014.10.016","article-title":"Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma?","volume":"51","author":"N\u00e4sman","year":"2015","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128077_bb0120","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128077_bb0125","article-title":"HPV vaccination adherence in working-age men: a systematic review and Meta-analysis","volume":"11","author":"Amantea","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128077_bb0130","doi-asserted-by":"crossref","first-page":"e1345","DOI":"10.1016\/S2214-109X(23)00305-4","article-title":"Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis","volume":"11","author":"Bruni","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128077_bb0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"issue":"37","key":"10.1016\/j.vaccine.2025.128077_bb0140","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1016\/j.vaccine.2013.06.057","article-title":"Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males","volume":"31","author":"Goldstone","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128077_bb0145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1464-410X.2010.09770.x","article-title":"Human papillomavirus prevalence, distribution and correlation to histopathological parameters in a large Swedish cohort of men with penile carcinoma","volume":"108","author":"Kirrander","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.vaccine.2025.128077_bb0150","series-title":"Health economic evaluation of universal HPV vaccination within the Swedish national vaccination programme for children","author":"Folkh\u00e4lsomyndigheten","year":"2017"},{"key":"10.1016\/j.vaccine.2025.128077_bb0155","series-title":"Datautdrag fr\u00e5n Kvalitetsregister f\u00f6r gynekologisk cancer","author":"Regionala Cancercentrum i samverkan","year":"2018"},{"key":"10.1016\/j.vaccine.2025.128077_bb0160","author":"Sveriges kommuner och regioner (SKR)"},{"key":"10.1016\/j.vaccine.2025.128077_bb0165","series-title":"Prislistor bild- och funktionsmedicin","author":"Region Sk\u00e5ne","year":"2024"},{"key":"10.1016\/j.vaccine.2025.128077_bb0170","series-title":"Prislista Avtalsl\u00e4kemedel Region Stockholm och Region Gotland mars","author":"Region Stockholm","year":"2024"},{"key":"10.1016\/j.vaccine.2025.128077_bb0175","series-title":"Upphandlade l\u00e4kemedel. Avtalade l\u00e4kemedel fr\u00e5n 1 mars 2023 (senast uppdaterad 2024-01-24)","author":"Region \u00d6sterg\u00f6tland","year":"2024"},{"key":"10.1016\/j.vaccine.2025.128077_bb0180","author":"Apoteket"},{"key":"10.1016\/j.vaccine.2025.128077_bb0185","author":"Apoteket"},{"key":"10.1016\/j.vaccine.2025.128077_bb0190","series-title":"Datautdrag fr\u00e5n F\u00f6rs\u00e4kringskassans statistikdatabas","author":"F\u00f6rs\u00e4kringskassan","year":"2021"},{"key":"10.1016\/j.vaccine.2025.128077_bb0195","author":"Skatteverket"},{"key":"10.1016\/j.vaccine.2025.128077_bb0200","series-title":"Samtliga sektorer (totalt m\u00e4n och kvinnor)","article-title":"L\u00f6nestrukturstatistik, hela ekonomin. Genomsnittlig m\u00e5nadsl\u00f6n efter sekton 1992\u20132022","author":"Statistiska centralbyr\u00e5n (SCB)","year":"2022"},{"key":"10.1016\/j.vaccine.2025.128077_bb0205","series-title":"Proceedings of the 21st International Papillomavirus Conference","article-title":"Patient preferences for health states related to HPV infection: visual analogue scales vs. time trade-off elicitation","author":"Myers","year":"2004"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128077_bb0210","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/sextrans-2011-050161","article-title":"Quality of life valuations of HPV-associated cancer health states by the general population","volume":"88","author":"Conway","year":"2012","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2025.128077_bb0215","series-title":"Metodbeskrivning f\u00f6r arbetet med nationella riktlinjer","author":"Socialstyrelsen","year":"2019"},{"key":"10.1016\/j.vaccine.2025.128077_bb0220","article-title":"Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands","volume":"28","author":"Simons","year":"2022","journal-title":"Prev Med Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:55:55Z","timestamp":1768452955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25013751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"alternative-id":["S0264410X25013751"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analyses of catch-up vaccination against human papillomavirus (HPV) related cancers of boys and young men in Sweden","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128077"}}